Many folks wonder what Microsoft’s eventual play in the life sciences will be. Clearly biomedical research looks more and more like an exercise in digital content integration, management, and mining. Within the last few years, Microsoft – and others – awakened to opportunities in healthcare writ large, and to biomedical research as a key piece of that enterprise.
To a large extent, Microsoft’s healthcare play has followed its traditional dependence in independent software vendor partners building solutions on top of Microsoft products. Yet its Amalga “product” is an enterprise-scale data integration solution sold directly to big hospitals, and apparently, Microsoft is building a specialized version of Amalga for the life sciences, which will be ready soon.
Where is Microsoft going in life sciences? .. Read more below...